BDF
GRCE

Balasa Dinverno & Foltz’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Balasa Dinverno & Foltz’s Portfolio GRCE Stock Details GRCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-448
Closed -$8K – 287
2020
Q1 		$8K Buy
448
+188
+72% +$3.36K ﹤0.01% 249
2019
Q4 		$31K Buy
+260
New +$31K ﹤0.01% 267